Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) With Avelumab in Muscle Invasive Bladder Cancer
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2019
Price : $35 *
At a glance
- Drugs Avelumab (Primary) ; Cisplatin; Fluorouracil; Mitomycin
- Indications Bladder cancer; Carcinoma; Urogenital cancer
- Focus Therapeutic Use
- 28 May 2019 Planned primary completion date changed from 31 Jul 2025 to 13 Nov 2019.
- 14 May 2019 Status changed from recruiting to active, no longer recruiting.
- 27 Nov 2018 Status changed from suspended to recruiting.